Basit öğe kaydını göster

dc.contributor.authorPazvantoglu, Ozan
dc.contributor.authorSimsek, Omer Faruk
dc.contributor.authorAydemir, Omer
dc.contributor.authorSarisoy, Gokhan
dc.contributor.authorKorkmaz, Isil Zabun
dc.contributor.authorMor, Sema
dc.contributor.authorUcok, Alp
dc.date.accessioned2020-06-21T14:17:56Z
dc.date.available2020-06-21T14:17:56Z
dc.date.issued2012
dc.identifier.issn1017-7833
dc.identifier.urihttps://doi.org/10.5455/bcp.20120731082335
dc.identifier.urihttps://hdl.handle.net/20.500.12712/16356
dc.descriptionSimsek, Omer/0000-0002-6113-7057;en_US
dc.descriptionWOS: 000311598000005en_US
dc.description.abstractReliability and validity of "subjective well-being under neuroleptics scale-short form", Turkish version Objective:The Subjective Well-Being Under Neuroleptics Scale (SWNS) is a self-reported measure that evaluates the state of well-being of schizophrenis patients using antipsychotic drugs independently of psychotic symptoms. This study was intended to establish the validity and reliability of the Turkish version of the scale. Methods: The Cronbach alpha coefficient was calculated for reliability analysis of the scale, which was translated into Turkish and applied to 103 schizophrenia patients. The criterion validity was examined by correlation with reference scales (Turkish Version of the Functional Remission of General Schizophrenia, The Short Form of the World Health Organization Quality of Life) concurrently in use. The construct validity of the scale was assured using both exploratory and confirmatory factor analyses. Findings: The Turkish version of the scale was found to have a high reliability co-efficient (0.881). In terms of total scores, the correlation with other scales is medium-good. However, the results of the Turkish version factor analysis were incompatible with the sub-dimensions of the original scale. Conclusions: Our findings show that the Turkish version of this scale is a valid and reliable tool in the evaluation of states of subjective well-being of schizophrenic patients using antipsychotic drugs. On the other hand, we recommend that studies to be conducted in Turkey use only the scale total score.en_US
dc.language.isoengen_US
dc.publisherKure Iletisim Grubu A Sen_US
dc.relation.isversionof10.5455/bcp.20120731082335en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectSchizophreniaen_US
dc.subjectThe SWNSen_US
dc.subjectsubjective well-beingen_US
dc.titleReliability and Validity of Subjective Well-Being Under Neuroleptics Scale-Short Form-Turkish Versionen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume22en_US
dc.identifier.issue3en_US
dc.identifier.startpage235en_US
dc.identifier.endpage243en_US
dc.relation.journalKlinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster